Dr. Amanda Elizabeth Austin, MD

Dr. Austin practices at East Alabama Medical Center in Opelika, Alabama, part of East Alabama Medical Center.

Dr. Austin's NPI, 1003044678, was assigned on June 23, 2009. Dr. Austin graduated from Medical College of Georgia School of Medicine in 2009. Dr. Austin holds Georgia license 003584.

Dr. Austin's primary practice is East Alabama Medical Center, at 2000 Pepperell Parkway, Opelika, AL 36801 in Lee County. The practice phone is (334) 528-1300.

Dr. Austin's primary practice is East Alabama Medical Center in Opelika, Alabama, part of East Alabama Medical Center. The medical group on file is Internal Medicine Associates, PC. Dmand AI also links Dr. Austin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Austin practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Austin's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Austin is board certified in internal medicine by the American Board of Internal Medicine. Dr. Austin is licensed in Georgia.

CMS data shows 764 Medicare services from Dr. Austin across 6 procedure codes in 2024, for 222 Medicare patients. Medicare paid $51,448 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 222 Medicare patients who saw Dr. Austin in 2024. The largest group is 75 to 84, with 80 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Austin's median patient age at 72, with 58% women.

In 2024, Dr. Austin wrote 263 Medicare Part D claims for 115 patients. 86% of them were for generic drugs. CMS names the drug for 94 of them, across 6 drugs with 11 or more claims each, at $522 in total drug cost. In 2023, CMS named 58 claims across 3 drugs.

Dr. Austin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Austin to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 82 general payments to Dr. Austin from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $476.

Dr. Austin graduated from Medical College of Georgia School of Medicine in 2009.